Long non-coding RNA TDRG1 aggravates lung cancer stemness by binding to Sox2 mRNA

You Lu1, Jing Cheng2, Qixing Mao2

  • 1Department of Interventional Radiology, Jiangsu Cancer Hospital & The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research, Nanjing, China.

Environmental Toxicology
|November 29, 2022
PubMed

Insights

Long non-coding RNA TDRG1 promotes lung cancer stemness by stabilizing Sox2 mRNA. This study reveals TDRG1 as a key regulator in lung cancer stem cell progression, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Long non-coding RNA TDRG1's role in various cancers is known, but its function in lung cancer stem cells (CSCs) remains unclear.
  • Cancer stem cells drive tumor progression and therapeutic resistance.
  • Understanding regulators of lung CSCs is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of lncRNA TDRG1 in lung CSC progression.
  • To elucidate the molecular mechanism by which TDRG1 affects lung CSCs.
  • To determine if TDRG1 is a potential therapeutic target in lung cancer.

Main Methods:

  • Established a 3D non-adherent sphere model for lung CSCs.
  • Measured lncRNA TDRG1 levels in lung CSCs and parental lung cancer cells.
  • Generated stable knockdown/overexpression cell lines for TDRG1.
  • Investigated the interaction between TDRG1 and Sox2 mRNA.
  • Assessed the impact of TDRG1 on lung cancer stemness.

Main Results:

  • TDRG1 was significantly upregulated in lung CSCs compared to parental cells.
  • TDRG1 overexpression enhanced lung cancer stemness, while knockdown reduced it.
  • TDRG1 directly binds to Sox2 mRNA, increasing its stability and expression.
  • TDRG1 promotes lung cancer stemness in a Sox2-dependent manner.

Conclusions:

  • TDRG1 acts as a critical promoter of lung cancer stemness.
  • TDRG1 stabilizes Sox2 mRNA, thereby enhancing stemness.
  • TDRG1 is a potential therapeutic target for lung cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K